With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.SCOTTSDALE, AZ / ACCESSWIRE / ...

We all have a unique face, fingerprint, voice and signature, so why wouldn’t we have a unique response to the medicine and ...

Pharmacovigilance (PV) is an essential component of drug safety that involves the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. As ...

DALLAS, TX / ACCESSWIRE / November 19, 2024 / Adnexus Biotechnologies Inc. is pleased to announce the appointment of Dr. Hiroshi Ohrui to its Scientific Advisory Board. Dr. Ohrui is a distinguished ...

As previously communicated, the planned Phase IIa study will be conducted in two parts. Part 1 aims to establish dosage levels and safety of sevuparin through single doses in 25-30 patients with ...

THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at ...

PHIOGEN, a biotech company developing live biotherapeutic products (LBPs) for drug-resistant and recurrent bacterial infections, is collaborating with patient research and advocacy organization Live ...

Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women's health, today announces a $10.4 million strategic investment from the Bill & Melinda Gates Foundation ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

PALO ALTO, CA / ACCESSWIRE / November 19, 2024 / Bioz, Inc., a driving force in AI-enhanced citation tracking, is pleased to announce a new partnership with DNA Polymerase Technology. By integrating ...

Commercial HighlightsAppointment of Jantzen Cole as Vice President of Market Development, Extremities, to drive the Company's acceleration beyond the spine marketStrategic expansion opens new ...

ExpansionSiegfried opens new global R&D Center for Drug Substances in Evionnaz 19.11.2024 / 07:03 CET/CESTMedia ReleaseZofingen, November 19, 2024Siegfried (SIX: SFZN), a leading global Contract ...